• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

《细胞减灭术联合热灌注腹腔化疗可提高晚期卵巢癌患者生存率且安全性可接受：100例患者的临床研究》勘误

Corrigendum to "Cytoreductive Surgery plus Hyperthermic Intraperitoneal Chemotherapy Improves Survival with Acceptable Safety for Advanced Ovarian Cancer: A Clinical Study of 100 Patients".

作者信息

Zhang Jue, Li Xin-Bao, Ji Zhong-He, Ma Ru, Bai Wen-Pei, Li Yan

机构信息

Department of Peritoneal Cancer Surgery, Beijing Shijitan Hospital, Capital Medical University, China.

Department of Gynecology, Beijing Shijitan Hospital, Capital Medical University, China.

出版信息

Biomed Res Int. 2021 Aug 23;2021:9789613. doi: 10.1155/2021/9789613. eCollection 2021.

DOI:10.1155/2021/9789613
PMID:34497856
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8421173/
Abstract

[This corrects the article DOI: 10.1155/2021/5533134.].

摘要

[本文更正文章DOI：10.1155/2021/5533134。]

相似文献

1
Corrigendum to "Cytoreductive Surgery plus Hyperthermic Intraperitoneal Chemotherapy Improves Survival with Acceptable Safety for Advanced Ovarian Cancer: A Clinical Study of 100 Patients".《细胞减灭术联合热灌注腹腔化疗可提高晚期卵巢癌患者生存率且安全性可接受：100例患者的临床研究》勘误
Biomed Res Int. 2021 Aug 23;2021:9789613. doi: 10.1155/2021/9789613. eCollection 2021.
2
Cytoreductive Surgery plus Hyperthermic Intraperitoneal Chemotherapy Improves Survival with Acceptable Safety for Advanced Ovarian Cancer: A Clinical Study of 100 Patients.细胞减灭术加腹腔热灌注化疗可提高晚期卵巢癌患者的生存率并具有可接受的安全性：100 例患者的临床研究。
Biomed Res Int. 2021 Jun 22;2021:5533134. doi: 10.1155/2021/5533134. eCollection 2021.
3
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for the treatment of advanced epithelial and recurrent ovarian carcinoma: a single center experience.细胞减灭术和腹腔内热灌注化疗治疗晚期上皮性和复发性卵巢癌：单中心经验。
Int J Hyperthermia. 2018 Aug;34(5):564-569. doi: 10.1080/02656736.2017.1371341. Epub 2017 Sep 7.
4
Primary cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy (HIPEC) for FIGO stage III epithelial ovarian cancer: OVHIPEC-2, a phase III randomized clinical trial.原发性细胞减灭术联合或不联合腹腔热灌注化疗（HIPEC）治疗国际妇产科联盟（FIGO）分期 III 期上皮性卵巢癌：OVHIPEC-2，一项 III 期随机临床试验。
Int J Gynecol Cancer. 2020 Jun;30(6):888-892. doi: 10.1136/ijgc-2020-001231. Epub 2020 Mar 23.
5
Peritoneal Carcinomatosis from Ovarian Cancer - Current Clinical Impact of Cytoreductive Surgery and Intraperitoneal Hyperthermic Chemotherapy.卵巢癌所致腹膜癌转移——肿瘤细胞减灭术及腹腔内热化疗的当前临床影响
Klin Onkol. 2019 Fall;32(5):349-352. doi: 10.14735/amko2019349.
6
Synchronous Liver Resection, Cytoreductive Surgery, and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Liver and Peritoneal Metastases: A Systematic Review and Meta-analysis.同步肝切除、细胞减灭术和腹腔内热灌注化疗治疗结直肠癌肝和腹膜转移：系统评价和荟萃分析。
Dis Colon Rectum. 2021 Jun 1;64(6):754-764. doi: 10.1097/DCR.0000000000002027.
7
Survival and complications of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in elderly patients: a systematic review and meta-analysis.老年患者细胞减灭术和腹腔内热化疗的生存和并发症：系统评价和荟萃分析。
Eur Rev Med Pharmacol Sci. 2021 Sep;25(17):5330-5348. doi: 10.26355/eurrev_202109_26640.
8
[Efficacy of 1 384 cases of peritoneal carcinomatosis underwent cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy].1384例腹膜癌病患者接受细胞减灭术加腹腔内热灌注化疗的疗效
Zhonghua Wei Chang Wai Ke Za Zhi. 2021 Mar 25;24(3):230-239. doi: 10.3760/cma.j.cn.441530-20201110-00603.
9
Timing of Systemic Chemotherapy in Patients With Colorectal Peritoneal Carcinomatosis Treated With Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.接受细胞减灭术和腹腔内热灌注化疗的结直肠癌腹膜转移患者全身化疗的时机
Dis Colon Rectum. 2017 May;60(5):477-487. doi: 10.1097/DCR.0000000000000774.
10
Retracted: Clinical Efficacy and Safety of Tumor Cytoreductive Surgery plus Hyperthermic Intraperitoneal Chemotherapy for Ovarian Cancer.撤回：肿瘤细胞减灭术联合腹腔热灌注化疗治疗卵巢癌的临床疗效与安全性
Evid Based Complement Alternat Med. 2023 Dec 13;2023:9824296. doi: 10.1155/2023/9824296. eCollection 2023.

本文引用的文献

1
Cytoreductive Surgery plus Hyperthermic Intraperitoneal Chemotherapy Improves Survival with Acceptable Safety for Advanced Ovarian Cancer: A Clinical Study of 100 Patients.细胞减灭术加腹腔热灌注化疗可提高晚期卵巢癌患者的生存率并具有可接受的安全性：100 例患者的临床研究。
Biomed Res Int. 2021 Jun 22;2021:5533134. doi: 10.1155/2021/5533134. eCollection 2021.